{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:09Z","timestamp":1792024209773,"version":"4.4.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T00:00:00Z","timestamp":1681603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cgh.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T07:07:36Z","timestamp":1681974456000},"page":"2150-2166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":327,"title":["Liver Transplantation 2023: Status Report, Current and Future Challenges"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-1950","authenticated-orcid":false,"given":"Norah A.","family":"Terrault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.04.005_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl\u00a02","key":"10.1016\/j.cgh.2023.04.005_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.16978","article-title":"OPTN\/SRTR 2020 Annual\u00a0Data Report: Liver","volume":"22","author":"Kwong","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jhep.2018.07.020","article-title":"A\u00a0changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over","volume":"69","author":"Terrault","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.14309\/ajg.0000000000001591","article-title":"Portrait of regional trends in liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"117","author":"Yuan","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.005_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"European Liver and Intestine Transplant Association (ELITA). Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/hepr.13364","article-title":"Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society","volume":"49","author":"Umeshita","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2023.04.005_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/lt.20024","article-title":"United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan","volume":"10","author":"Freeman","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trre.2009.10.002","article-title":"Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target","volume":"24","author":"Washburn","year":"2010","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.cgh.2023.04.005_bib14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.cgh.2023.04.005_bib15","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","article-title":"Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD","volume":"42","author":"Durand","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib16","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin c-based equations: systematic review and meta-analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.30321","article-title":"A\u00a0model for glomerular filtration rate assessment in liver disease (GRAIL) in the presence of renal dysfunction","volume":"69","author":"Asrani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2010.07.015","article-title":"Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate","volume":"54","author":"Myers","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/lt.20195","article-title":"Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation","volume":"10","author":"Trotter","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib23","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1111\/ajt.15559","article-title":"The decreasing predictive power of MELD in an era of changing etiology of liver disease","volume":"19","author":"Godfrey","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib24","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: the model for End-Stage Liver Disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12072-015-9631-3","article-title":"Model for end-stage liver disease score and MELD exceptions: 15 years later","volume":"9","author":"Asrani","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2023.04.005_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/lt.22363","article-title":"Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system","volume":"17","author":"Francoz","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.27830","article-title":"Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis","volume":"62","author":"Tapper","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2014.02.026","article-title":"Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography","volume":"60","author":"Durand","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/hep.32268","article-title":"Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Frailty, mortality, and health care utilization after liver transplantation: from the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study","volume":"75","author":"Lai","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"CANONIC Study Investigators of the EASL-CLIF Consortium. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2021.03.030","article-title":"ELITA\/EF-CLIF working group. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA\/EF-CLIF collaborative study (ECLIS)","volume":"75","author":"Belli","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/apt.15988","article-title":"Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy","volume":"52","author":"Sundaram","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.005_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/lt.25426","article-title":"Outcomes after listing for liver transplant in patients with acute-on-chronic liver failure: the multicenter North American Consortium for the Study of End-Stage Liver Disease Experience","volume":"25","author":"O\u2019Leary","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13115","article-title":"Liver transplantation in critically ill patients: preoperative predictive factors of post-transplant mortality to avoid futility","volume":"31","author":"Michard","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/MEG.0000000000001467","article-title":"Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes","volume":"31","author":"Marciano","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/liv.13355","article-title":"Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation","volume":"37","author":"Levesque","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2023.04.005_bib38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/apt.14627","article-title":"Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival","volume":"47","author":"Huebener","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.005_bib39","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/ajt.15852","article-title":"Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors","volume":"20","author":"Artzner","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib41","first-page":"659","article-title":"Homotransplantation of the liver in humans","volume":"117","author":"Starzl","year":"1963","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cgh.2023.04.005_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.722098","article-title":"Outcomes of living donor liver transplantation in patients with a history of ruptured hepatocellular carcinoma","volume":"8","author":"Lee","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib44","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.ejso.2019.03.044","article-title":"Impact of spontaneous rupture on the survival outcomes after liver resection for hepatocellular carcinoma: a propensity matched analysis comparing ruptured versus non-ruptured tumors","volume":"45","author":"Chua","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.cgh.2023.04.005_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation","volume":"62","author":"Toso","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/cancers12051275","article-title":"Potential circulating biomarkers of recurrence after hepatic resection or liver transplantation in hepatocellular carcinoma patients","volume":"12","author":"Duda","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cgh.2023.04.005_bib47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/lt.24117","article-title":"Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation","volume":"21","author":"Chaiteerakij","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib48","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1600-6143.2009.02783.x","article-title":"Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma","volume":"9","author":"Fujiki","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.08.067","article-title":"Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma. Review article","volume":"22","author":"Mouchli","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.31165","article-title":"Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma","volume":"73","author":"Ahn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib51","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1097\/TXD.0000000000000814","article-title":"Liver allograft failure after nivolumab treatment-a case report with systematic literature research","volume":"4","author":"Gassmann","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cgh.2023.04.005_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/lt.21785","article-title":"Liver transplantation at the extremes of the body mass index","volume":"15","author":"Dick","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib55","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1097\/TP.0000000000001461","article-title":"Higher mortality and survival benefit in obese patients awaiting liver transplantation","volume":"100","author":"Schlansky","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/tri.12017","article-title":"The impact of wait list body mass index changes on the outcome after liver transplantation","volume":"26","author":"Orci","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2023.04.005_bib57","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/lt.24188","article-title":"Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: risk modulated by model for end-stage liver disease","volume":"21","author":"Bambha","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib58","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib59","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jgh.13240","article-title":"Australian New Zealand Liver Transplant Study Group. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant","volume":"31","author":"Adams","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154204","article-title":"Post-transplant obesity impacts long-term survival after liver transplantation","volume":"106","author":"van Son","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.cgh.2023.04.005_bib61","first-page":"646","article-title":"Listing practices for morbidly obese patients at liver transplantation centers in the United States","volume":"14","author":"Halegoua-De Marzio","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/SLA.0b013e31818a01ef","article-title":"Prolonged waiting times for liver transplantation in obese patients","volume":"248","author":"Segev","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib63","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of >\/= 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.005_bib64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib65","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib66","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","article-title":"Weight and metabolic outcomes 12 years after gastric bypass","volume":"377","author":"Adams","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib67","article-title":"Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis","volume":"5","author":"Villeret","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2023.04.005_bib68","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib69","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.14309\/ajg.0000000000000911","article-title":"Improving outcomes of bariatric surgery in patients with cirrhosis in the United States: a nationwide assessment","volume":"115","author":"Are","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.005_bib70","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s11695-015-1623-9","article-title":"Laparoscopic adjustable gastric banding in patients with unexpected cirrhosis: safety and outcomes","volume":"25","author":"Woodford","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.soard.2013.02.013","article-title":"Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates","volume":"9","author":"Lin","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.cgh.2023.04.005_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mayocp.2014.11.012","article-title":"Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience","volume":"90","author":"Pestana","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2023.04.005_bib73","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1007\/s11695-020-04929-y","article-title":"Bariatric surgery in cirrhotic patients: a matched case-control study","volume":"30","author":"Quezada","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib74","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/lt.25406","article-title":"Outcomes of sleeve gastrectomy in obese liver transplant candidates","volume":"25","author":"Sharpton","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/lt.25368","article-title":"Impact of prior bariatric surgery on perioperative liver transplant outcomes","volume":"25","author":"Idriss","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-6143.2012.04318.x","article-title":"Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease","volume":"13","author":"Heimbach","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib77","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11695-017-2634-5","article-title":"Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity?","volume":"27","author":"Nesher","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.29848","article-title":"Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy","volume":"68","author":"Zamora-Valdes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib79","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1007\/s11695-022-06289-1","article-title":"Combined sleeve gastrectomy with liver transplant in patients with obesity: a feasibility study","volume":"32","author":"Gunturu","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib80","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/lt.25637","article-title":"Delayed sleeve gastrectomy following liver transplantation: a 5-year experience","volume":"25","author":"Morris","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/lt.23567","article-title":"Innovative approach using an intragastric balloon for weight loss in a morbidly obese patient undergoing liver transplantation","volume":"19","author":"Choudhary","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib82","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/lt.26074","article-title":"Efficacy and safety of endoscopic balloon placement for weight loss in patients with cirrhosis awaiting liver transplantation","volume":"27","author":"Watt","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"SURPASS-2 Investigators. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cgh.2023.04.005_bib86","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hep4.1747","article-title":"Alcohol-associated liver disease before and After COVID-19-an overview and call for ongoing investigation","volume":"5","author":"Moon","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2023.04.005_bib87","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jhep.2022.07.008","article-title":"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper","volume":"77","author":"Marjot","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib88","doi-asserted-by":"crossref","first-page":"e1170","DOI":"10.1016\/j.cgh.2021.10.030","article-title":"Impact of the COVID-19 pandemic on hospitalizations for alcoholic hepatitis or cirrhosis in Alberta, Canada","volume":"20","author":"Shaheen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib89","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/hep.32067","article-title":"Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the USA","volume":"74","author":"Cholankeril","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib90","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2023.04.005_bib91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajt.15276","article-title":"OPTN\/SRTR 2017 Annual Data Report: Liver","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib92","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib93","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"European Liver and Intestine Transplant Association (ELITA). Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry","volume":"69","author":"Belli","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib94","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib95","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/TP.0000000000001156","article-title":"Liver transplantation for alcoholic liver disease","volume":"100","author":"Addolorato","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib96","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/tgh.2020.02.22","article-title":"Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients","volume":"7","author":"Shenoy","year":"2022","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrgastro.2013.247","article-title":"Liver transplantation for alcoholic liver disease","volume":"11","author":"Lucey","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib98","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/lt.25681","article-title":"Meeting report: the Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis","volume":"26","author":"Asrani","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib99","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States--a single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jamcollsurg.2017.12.044","article-title":"Liver transplantation for severe alcoholic hepatitis, updated lessons from the world\u2019s largest series","volume":"226","author":"Weeks","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib102","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib103","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2468-1253(21)00430-1","article-title":"QuickTrans trial study group. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study","volume":"7","author":"Louvet","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib104","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/hep4.1390","article-title":"Patients\u2019 perspectives on early liver transplantation in alcohol-related liver disease","volume":"3","author":"Wong","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2023.04.005_bib105","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/lt.25783","article-title":"Debate on selection criteria for liver transplantation for alcoholic hepatitis: tighten or loosen?","volume":"26","author":"Im","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOT.0000000000000507","article-title":"Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus","volume":"23","author":"Lee","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib107","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.25188","article-title":"Liver transplantation for alcoholic hepatitis: being consistent about where to set the bar","volume":"24","author":"Thursz","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib108","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/gut.45.3.421","article-title":"Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism","volume":"45","author":"Pageaux","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.04.005_bib109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cgh.2020.11.024","article-title":"Patterns of alcohol use after early liver transplantation for alcoholic hepatitis","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib111","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib112","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2019.12.023","article-title":"Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey\u2019s discriminant function <32","volume":"72","author":"Degre","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib113","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib114","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.32110","article-title":"Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis","volume":"75","author":"Musto","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","article-title":"The MELD score is superior to the Maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: a global study","volume":"117","author":"Morales-Arraez","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.005_bib117","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ajt.16936","article-title":"Liver transplantation for severe alcoholic hepatitis: a multicenter Italian study","volume":"22","author":"Germani","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib118","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.25460","article-title":"Prediction of alcohol relapse among liver transplant candidates with less than 6 months of abstinence using the high-risk alcoholism relapse score","volume":"25","author":"Lombardo-Quezada","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib119","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/lt.25579","article-title":"Identifying risk of alcohol relapse after liver transplantation: what tools do we need?","volume":"25","author":"Shen","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib120","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.30478","article-title":"Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib121","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10620-019-05937-4","article-title":"Prior relapse, ongoing alcohol consumption, and failure to engage in treatment predict alcohol relapse after liver transplantation","volume":"65","author":"Deutsch-Link","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.005_bib122","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/lt.25641","article-title":"Integration of an addiction team in a liver transplantation center","volume":"25","author":"Donnadieu-Rigole","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib123","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41575-022-00723-6","article-title":"Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantation","volume":"20","author":"Arab","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib125","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors","volume":"19","author":"Kwong","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib126","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/hep.31551","article-title":"Prevention of de novo HCV with antiviral HCV therapy post-liver and post-kidney transplant: a multicenter, prospective, safety and efficacy study of pre-emptive, pangenotypic antiviral therapy","volume":"73","author":"Terrault","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib127","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/ajt.15768","article-title":"Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: implications for therapeutic planning","volume":"20","author":"Bethea","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib128","first-page":"53","article-title":"Acute liver graft cellular rejection after interferon-free antiviral treatment for HCV infection. Is there a risk? A warning about three cases","volume":"82","author":"Dahlqvist","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cgh.2023.04.005_bib129","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/ajt.15053","article-title":"Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy","volume":"18","author":"Chan","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jhep.2019.03.003","article-title":"Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis","volume":"70","author":"Wong","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from anti-hepatitis B core positive donors: a systematic review","volume":"52","author":"Cholongitas","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib132","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1665-2681(19)31550-9","article-title":"Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient","volume":"10","author":"Bahde","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib133","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/lt.20471","article-title":"Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection","volume":"11","author":"Franchello","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib134","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/jmv.27703","article-title":"Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease","volume":"94","author":"Yu","year":"2022","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cgh.2023.04.005_bib135","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000168","article-title":"The matching status between donor and recipient hepatitis B seroepidemiology makes a difference in liver transplantation for hepatocellular carcinoma","volume":"11","author":"Lu","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.005_bib136","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/jgh.15821","article-title":"Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: a matched study based on a national registry cohort","volume":"37","author":"Yu","year":"2022","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib137","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2014.05.003","article-title":"Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation","volume":"61","author":"Yu","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib138","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jvh.12880","article-title":"Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation","volume":"25","author":"Lee","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2023.04.005_bib139","first-page":"593","article-title":"Improved survival after liver transplantation for patients with HIV and HIV\/HCV coinfection in the INSTI and DAA eras","volume":"18","author":"Jacob","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2023.04.005_bib140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ajt.16886","article-title":"HOPE in Action Investigators. HOPE in Action: a prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV","volume":"22","author":"Durand","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib141","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib142","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S2352-3018(20)30200-9","article-title":"Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study","volume":"7","author":"Bonny","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cgh.2023.04.005_bib143","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s40472-021-00345-y","article-title":"Science over stigma: lessons and future direction of HIV-to-HIV transplantation","volume":"8","author":"Klitenic","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.cgh.2023.04.005_bib144","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/ajt.17126","article-title":"Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States","volume":"22","author":"Schold","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib145","article-title":"Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: a systematic review","volume":"41","author":"Martinez-Reviejo","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib146","doi-asserted-by":"crossref","first-page":"ofac221","DOI":"10.1093\/ofid\/ofac221","article-title":"Risk of severe acute respiratory syndrome coronavirus 2 transmission through solid organ transplantation and outcomes of coronavirus disease 2019 among recent transplant recipients","volume":"9","author":"Free","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cgh.2023.04.005_bib147","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/TP.0000000000004032","article-title":"Successful liver transplantation from a SARS-CoV-2 positive donor to a positive recipient: potential role of monoclonal antibodies","volume":"106","author":"Yetmar","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib148","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/TP.0000000000002535","article-title":"International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients: Erratum","volume":"103","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib149","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0029-1192059","article-title":"Long-term care of the liver allograft recipient","volume":"29","author":"Mells","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2023.04.005_bib150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.27538","article-title":"Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study","volume":"61","author":"Aberg","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib151","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib152","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41575-020-0334-4","article-title":"Understanding, predicting and achieving liver transplant tolerance: from bench to bedside","volume":"17","author":"Thomson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2017.10.007","article-title":"Tolerance in clinical liver transplantation","volume":"79","author":"Levitsky","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cgh.2023.04.005_bib154","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib155","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Benitez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib156","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2023.04.005_bib157","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cei.12988","article-title":"Immune monitoring as prerequisite for transplantation tolerance trials","volume":"189","author":"Behnam Sani","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cgh.2023.04.005_bib158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOT.0000000000000959","article-title":"Biomarkers of rejection in liver transplantation","volume":"27","author":"Perottino","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib159","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/eji.202048875","article-title":"Advances in liver transplantation: where are we in the pursuit of transplantation tolerance?","volume":"51","author":"Safinia","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cgh.2023.04.005_bib160","article-title":"Ischaemia-free liver transplantation in humans: a first-in-human trial","volume":"16","author":"Guo","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.cgh.2023.04.005_bib161","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SLA.0000000000003513","article-title":"Novel real-time prediction of liver graft function during hypothermic oxygenated machine perfusion before liver transplantation","volume":"270","author":"Muller","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib162","article-title":"Defatting strategies in the current era of liver steatosis","volume":"3","author":"Mazilescu","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2023.04.005_bib163","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation - a randomized trial","volume":"384","author":"van Rijn","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827535","article-title":"Current barriers to clinical liver xenotransplantation","volume":"13","author":"Cross-Najafi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cgh.2023.04.005_bib165","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/SLA.0000000000001659","article-title":"A\u00a0bridge to somewhere: 25-day survival after pig-to-baboon liver xenotransplantation","volume":"263","author":"Shah","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib166","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/ajt.14341","article-title":"Prolonged survival following pig-to-primate liver xenotransplantation utilizing exogenous coagulation factors and costimulation blockade","volume":"17","author":"Shah","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib167","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib168","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.16930","article-title":"First clinical-grade porcine kidney xenotransplant using a human decedent model","volume":"22","author":"Porrett","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.005_bib169","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa2120238","article-title":"Results of two cases of pig-to-human kidney xenotransplantation","volume":"386","author":"Montgomery","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2023.04.005_bib170","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12497","article-title":"A\u00a0review of pig liver xenotransplantation: current problems and recent progress","volume":"26","author":"Zhang","year":"2019","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib171","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1399-3089.2012.00693.x","article-title":"Xenotransplantation-associated infectious risk: a WHO consultation","volume":"19","author":"Fishman","year":"2012","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.cgh.2023.04.005_bib173","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.005_bib174","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lt.25807","article-title":"Comparison of wait-list mortality between cholangiocarcinoma and hepatocellular carcinoma liver transplant candidates","volume":"26","author":"Ziogas","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib175","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.005_bib176","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2023.04.005_bib177","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Methodist\u2013MD Anderson Joint Cholangiocarcinoma Collaborative Committee (MMAJCCC). Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.005_bib178","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","article-title":"Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?","volume":"261","author":"Dueland","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib179","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/bjs.10769","article-title":"Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma","volume":"105","author":"Dueland","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2023.04.005_bib180","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523002781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523002781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:42:59Z","timestamp":1761543779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523002781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":174,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1542356523002781"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.005","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Transplantation 2023: Status Report, Current and Future Challenges","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}